Jonathan Mayo of MLB.com looks at the two non-Melkys in the Vazquez deal. He says Arodys Vizcaino “looks like a high-end rotation prospect with a ton of upside.” Of course at 19 it’s way too early to know what he’ll turn into. As for Michael Dunn: he sounds like Ebby Calvin “Nuke” LaLoosh. Well, maybe not that extreme, but definitely a good stuff, bad command kind of guy.
Meanwhile, everyone who wants to dump on the Braves end of the trade seems to forget that in addition to Melky and the pitchers, the Braves got $9-10 million bucks to play with as a result of not having to pay Vazquez. Jayson Stark suggests Dan Uggla or Xavier Nady. Ken Rosenthal wonders whether Mark DeRosa, Marlon Byrd or Adam LaRoche could sign with Atlanta.
Not sure how I feel about any of those guys, but the point is this: the Braves may not have gotten the best deal from the Yankees and should have tried to do better, but unless they really screw up the spending of the Vazquez dividend, they are likely to be a stronger team on opening day than they were when we woke up this morning, and that’s the name of the game, isn’t it?
Blue Jays right-hander Marcus Stroman might be headed to the disabled list soon, manager John Gibbons told reporters following Friday’s rain-shortened loss to the Yankees. The righty lasted just four innings on the mound before calling it a night, and gave up five runs, six hits and two walks in a performance that Gibbons claimed was at least partially affected by recurring blister issues on his right middle finger. Now, it looks like he might be removed from the rotation for some much-needed rest and rehabilitation; if so, it’ll be his second such stint this year.
Stroman, 27, has struggled to return the kind of winning record and sub-4.00 ERA that characterized his previous seasons with the club, mostly due to the combined seven weeks he missed with blisters on his throwing hand and chronic fatigue in his right shoulder. In a recent start against the Rays, things got even more gruesome when his blister appeared to start bleeding in the middle of his outing and MLB.com’s Gregor Chisholm notes that the wound has constantly interfered with the right-hander’s pitch selection and delivery. When healthy, Stroman has managed a 4-8 record through 18 starts in 2018 with a career-worst 5.27 ERA, 3.2 BB/9 and 6.8 SO/9 in 100 2/3 innings. This will be the first year since 2015 in which he has not logged at least 200 innings in a single season.
While Stroman may not need an extended stay on the DL before he returns to the mound, it’s not clear what kind of timetable the Blue Jays expect for his recovery. He’s been the second-most valuable starter (behind the now-traded J.A. Happ) in a rotation that currently ranks 17th in the majors with a combined 4.90 ERA and 6.8 fWAR.